Replies to post #1827 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s pro forma cash @9/30/20=$445.3M—a decrease of $9.6M since 6/30/20 and an increase of $1.1M since 9/30/19 (#msg-152977520).

The $445.3M figure above consists of: $412.7M of net current assets on the 9/30/20 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/1177648/000156459020055233/enta-10k_20200930.htm#CONSOLIDATED_BALANCE_SHEETS ); and $32.6M of marketable securities on the 9/30/20 balance sheet designated as long-term (e.g. bonds with a time to maturity greater than one year).